Covalent nano delivery systems for selective imaging and treatment of brain tumors.

about

Covalent nano delivery systems for selective imaging and treatment of brain tumors.

Item

http://www.wikidata.org/entity/Q39367664

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Covalent nano delivery systems for selective imaging and treatment of brain tumors.

@en

Covalent nano delivery systems for selective imaging and treatment of brain tumors.

@nl

type

Item

label

Covalent nano delivery systems for selective imaging and treatment of brain tumors.

@en

Covalent nano delivery systems for selective imaging and treatment of brain tumors.

@nl

prefLabel

Covalent nano delivery systems for selective imaging and treatment of brain tumors.

@en

Covalent nano delivery systems for selective imaging and treatment of brain tumors.

@nl

P1476

Covalent nano delivery systems for selective imaging and treatment of brain tumors.

@en

P2093

Alexander V Ljubimov

http://www.w3.org/2001/XMLSchema#string

Eggehard Holler

http://www.w3.org/2001/XMLSchema#string

Julia Y Ljubimova

http://www.w3.org/2001/XMLSchema#string

Tao Sun

http://www.w3.org/2001/XMLSchema#string

Vida Falahatian

http://www.w3.org/2001/XMLSchema#string

Vladimir A Ljubimov

http://www.w3.org/2001/XMLSchema#string

P2860

The blood-brain barrier: bottleneck in brain drug development

Human gamma-glutamyl hydrolase: cloning and characterization of the enzyme expressed in vitro

RNA-guided human genome engineering via Cas9

Multiplex genome engineering using CRISPR/Cas systems

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Renal clearance of quantum dots.

The 2007 WHO classification of tumours of the central nervous system

Microbial synthesis of poly-γ-glutamic acid: current progress, challenges, and future perspectives

New perspectives in glioblastoma antiangiogenic therapy

Advances in therapeutic CRISPR/Cas9 genome editing

P304

177-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADDR.2017.06.002

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Liron Israel

Leila Mashouf

P577

2017-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28606739

http://www.w3.org/2001/XMLSchema#string

P932

5578712

http://www.w3.org/2001/XMLSchema#string